GE HealthCare stock trades 26.4 percent below its yearly high

Published on 09/24/2026 at 13:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GE HealthCare stock stood at USD 66.09 on Nasdaq on September 23, 2026, after a CFO transition. Second-quarter revenue reached USD 5.295 billion, with EPS at USD 1.24.

Techniker bedient MRT-Scanner in hellem Krankenhaus-Untersuchungsraum mit Flurblick — GE HealthCare US36266G1076 zeigt einen modernen MRT-Scanner im hellen klinischen Krankenhaus mit Techniker, Illustration mit AI erstellt.

GE HealthCare stock (ISIN US36266G1076) stood at USD 66.09 on Nasdaq on September 23, 2026, down USD 0.18 or 0.27 percent from the prior session. The price was 26.4 percent below its 52-week high of USD 89.77, giving the stock a clear valuation reference after a difficult run.

CFO transition sets the tone

William Grogan took over as GE HealthCare's chief financial officer on September 14, 2026, succeeding Jay Saccaro. Reuters reported the appointment on August 18, 2026, making the leadership change the most recent company-specific event in the market narrative.

The transition comes as GE HealthCare manages a large medical technology portfolio spanning imaging, ultrasound, patient care and pharmaceutical diagnostics. The company profile lists 54,000 full-time employees, while its Chicago headquarters supports operations across international healthcare markets.

Second-quarter figures show operating scale

For the quarter ended June 30, 2026, GE HealthCare reported revenue of USD 5.295 billion, operating profit of USD 739 million and consolidated net income of USD 573 million. The reported diluted EPS was USD 1.24, compared with USD 0.85 in the first quarter of 2026.

The second-quarter revenue was 3.2 percent above the USD 5.131 billion reported for the first quarter, while the operating margin improved from 10.0 percent to 14.0 percent. GE HealthCare published the second-quarter results for the period ended June 30, 2026.

Stock remains below its yearly high

GE HealthCare's market capitalization was USD 29,851,944,395 as of September 23, 2026. With a 52-week range of USD 58.75 to USD 89.77, the USD 66.09 price sat USD 7.34 above the yearly low and USD 23.68 below the yearly high.

The numbers frame the investment debate in practical terms: quarterly profitability improved sequentially, but the share price remained much nearer its yearly low than its yearly high. The new CFO therefore inherits a business with measurable operating progress and a stock valuation that still reflects execution concerns.

Nasdaq price snapshot

GE HealthCare stock stood at USD 66.09 on Nasdaq on September 23, 2026, with a daily change of minus 0.27 percent. The reference price, market capitalization and 52-week range point to a company valued at USD 29,851,944,395 while the share remains 26.4 percent below its yearly high.